NYMXF — NYMOX PHARMACEUTICAL CORP
—
OTC ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1018735 ·
Last close
$0.03
Market Cap
$3.15M
52W High
$0.20
52W Low
$0.00
ADV30
23,030
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-717,000
Investing CF
$0
Financing CF
$750,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-212,474,000
Inventory
—
Receivables
$27,000
ST Investments
—
EBIT TTM
$-771,000
Pretax Income TTM
$-857,000
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -3,677,000 | -4,275,000 | 576,000 | 9,881,000 | -9,305,000 | -1,806,000 |
| Dec 2024 | 0 | -4,283,000 | -4,492,000 | 654,000 | 7,429,000 | -6,775,000 | -2,601,000 |
| Dec 2023 | 0 | -8,350,000 | -8,844,000 | 627,000 | 3,800,000 | -3,173,000 | -4,057,000 |
| Dec 2022 | 0 | -6,652,000 | -6,576,000 | 1,625,000 | 2,107,000 | -482,000 | -5,205,000 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VSBC | VITASPRING BIOMEDICAL CO. LTD. | $3.21M | $0.02 | — |
| BUDZ | WEED, INC. | $2.97M | $0.02 | — |
| QCLS | Q/C TECHNOLOGIES, INC. | $2.74M | $0.33 | — |
| BIAF | bioAffinity Technologies, Inc. | $2.48M | $1.93 | — |
| TRIB | TRINITY BIOTECH PLC | $4.89M | $6.01 | — |
News headlines (Yahoo Finance, 1h cache)
NYMOX Provides Current Update
2026-06-02 20:00 · Yahoo
Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean
2026-06-17 14:45 · Yahoo
NYMOX Provides Recent Updates
2026-03-27 20:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.